340B Drug Pricing Program
AHA amicus brief defending Kansas’ 340B Contract Pharmacy Law in ABBVIE INC., et al., case.
AHA releases Regulatory Advisory summarizing CMS final guidance on implementation of the Medicare Drug Price Negotiation Program
The Centers for Medicare & Medicaid Services (CMS) Oct. 2 released its final guidance on implementing the Inflation Reduction Act’s (IRA) Medicare Drug Price Negotiation Program.
The AHA, 340B Health, the Minnesota Hospital Association and American Society of Health-System Pharmacists Oct. 4 filed two amicus briefs in the U.S. District Court for the District of Minnesota, defending the state's law protecting 340B pricing for contract pharmacy arrangements.
The AHA, 340B Health, the Minnesota Hospital Association and American Society of Health-system Pharmacists Oct. 4 filed an amicus brief in the U.S. District Court for the District of Minnesota, defending the state's law protecting 340B pricing for contract pharmacy arrangements.
Amicus Brief: ABBVIE INC., et al., v. Keith M. Ellison, in his official capacity as Attorney General of Minnesota Motion to Dismiss 340B Litigation
Amicus Brief: Motion to Dismiss in Astrazeneca Pharmaceuticals LP v Plaintiff, Attorney General of the State of Minnesota in 340B litigation.
The Department of Health and Human Services Oct. 2 released final guidance detailing the process for the second cycle of negotiations under the Medicare Drug Price Negotiation Program.
A Louisiana district court yesterday upheld a state law prohibiting drug companies from denying Louisiana hospitals 340B discounts for drugs dispensed at community pharmacies.
A Louisiana district court Sept. 30 upheld a state law prohibiting drug companies from denying Louisiana hospitals 340B discounts for drugs dispensed at community pharmacies.